A multidisciplinary research team at McMaster University in Canada has revealed the mechanism that may lead to some patients developing serious blood clots after receiving heparin, a common blood thinner.
The study explained how a normal protein in the blood can become a target for harmful antibodies, leading to an immune condition known as "heparin-induced thrombocytopenia" (HIT).
The researchers focused on platelet factor 4 (PF4), a natural protein that plays a role in blood clotting. In some patients receiving heparin, this protein can change shape, making it a target for antibodies that activate an immune response that may lead to the formation of dangerous clots. These clots can cause stroke, heart attack, or limb loss, and may be life-threatening if not diagnosed and treated quickly.
Using nuclear magnetic resonance (NMR) spectroscopy, researchers identified what they described as a "molecular switch" within the PF4 protein that controls its shape. They showed that keeping the protein in its closed state significantly reduces its ability to elicit an immune response, suggesting that this mechanism could be used to develop new diagnostic or therapeutic methods.
The results were the product of a collaboration between researchers in chemistry, structural biology, medicine and transfusion medicine, led by Giuseppe Melacini and Isaac Nazi, along with postdoctoral researcher Chiu Lin Ma.
Melacini said that identifying the structural change that turns PF4 into a disease-causing antigen provides a new approach that can be used to detect or prevent dangerous immune reactions, while Nazi noted that combining molecular imaging techniques and clinical expertise helped the team explain why the protein becomes a target for harmful antibodies.
The researchers believe the findings could pave the way for the development of more accurate diagnostic tests for the early detection of disease-causing antibodies, allowing for earlier intervention and reducing complications. The approach used in the study may also provide a model for investigating other diseases linked to subtle structural changes in proteins that affect their function.
what is your opinion on this news ?do let us know in the comments on tha comment box
if you liked this news article please share on friends & family & don't forget to follow on website & social media
